Medical Care
Global CD55 Antibody Market Research Report 2025
- May 12, 25
- ID: 236052
- Pages: 98
- Figures: 93
- Views: 8
The global market for CD55 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
CD55 (decay-accelerating factor, DAF) is a GPI-anchored membrane glycoprotein that protects autologous cells from classical and alternative pathway of complement cascade.
North American market for CD55 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CD55 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CD55 Antibody in Immunochemistry (IHC) is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CD55 Antibody include Merck, Thermo Fisher Scientific, Proteintech Group, Aviva Systems Biology, LifeSpan BioSciences, RayBiotech, Leading Biology, ProSci, Bethyl Laboratories, OriGene Technologies, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CD55 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD55 Antibody.
The CD55 Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD55 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD55 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Thermo Fisher Scientific
Proteintech Group
Aviva Systems Biology
LifeSpan BioSciences
RayBiotech
Leading Biology
ProSci
Bethyl Laboratories
OriGene Technologies
Novus Biologicals
Cell Signaling Technology
Abcam
GeneTex
United States Biological
St John's Laboratory
Creative Diagnostics
Biobyt
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CD55 Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
CD55 (decay-accelerating factor, DAF) is a GPI-anchored membrane glycoprotein that protects autologous cells from classical and alternative pathway of complement cascade.
North American market for CD55 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CD55 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CD55 Antibody in Immunochemistry (IHC) is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CD55 Antibody include Merck, Thermo Fisher Scientific, Proteintech Group, Aviva Systems Biology, LifeSpan BioSciences, RayBiotech, Leading Biology, ProSci, Bethyl Laboratories, OriGene Technologies, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CD55 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD55 Antibody.
The CD55 Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD55 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD55 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Thermo Fisher Scientific
Proteintech Group
Aviva Systems Biology
LifeSpan BioSciences
RayBiotech
Leading Biology
ProSci
Bethyl Laboratories
OriGene Technologies
Novus Biologicals
Cell Signaling Technology
Abcam
GeneTex
United States Biological
St John's Laboratory
Creative Diagnostics
Biobyt
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CD55 Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD55 Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global CD55 Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD55 Antibody Market Perspective (2020-2031)
2.2 Global CD55 Antibody Growth Trends by Region
2.2.1 Global CD55 Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CD55 Antibody Historic Market Size by Region (2020-2025)
2.2.3 CD55 Antibody Forecasted Market Size by Region (2026-2031)
2.3 CD55 Antibody Market Dynamics
2.3.1 CD55 Antibody Industry Trends
2.3.2 CD55 Antibody Market Drivers
2.3.3 CD55 Antibody Market Challenges
2.3.4 CD55 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CD55 Antibody Players by Revenue
3.1.1 Global Top CD55 Antibody Players by Revenue (2020-2025)
3.1.2 Global CD55 Antibody Revenue Market Share by Players (2020-2025)
3.2 Global CD55 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CD55 Antibody Revenue
3.4 Global CD55 Antibody Market Concentration Ratio
3.4.1 Global CD55 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD55 Antibody Revenue in 2024
3.5 Global Key Players of CD55 Antibody Head office and Area Served
3.6 Global Key Players of CD55 Antibody, Product and Application
3.7 Global Key Players of CD55 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CD55 Antibody Breakdown Data by Type
4.1 Global CD55 Antibody Historic Market Size by Type (2020-2025)
4.2 Global CD55 Antibody Forecasted Market Size by Type (2026-2031)
5 CD55 Antibody Breakdown Data by Application
5.1 Global CD55 Antibody Historic Market Size by Application (2020-2025)
5.2 Global CD55 Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CD55 Antibody Market Size (2020-2031)
6.2 North America CD55 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CD55 Antibody Market Size by Country (2020-2025)
6.4 North America CD55 Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CD55 Antibody Market Size (2020-2031)
7.2 Europe CD55 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CD55 Antibody Market Size by Country (2020-2025)
7.4 Europe CD55 Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CD55 Antibody Market Size (2020-2031)
8.2 Asia-Pacific CD55 Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CD55 Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific CD55 Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CD55 Antibody Market Size (2020-2031)
9.2 Latin America CD55 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CD55 Antibody Market Size by Country (2020-2025)
9.4 Latin America CD55 Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CD55 Antibody Market Size (2020-2031)
10.2 Middle East & Africa CD55 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CD55 Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa CD55 Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck CD55 Antibody Introduction
11.1.4 Merck Revenue in CD55 Antibody Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific CD55 Antibody Introduction
11.2.4 Thermo Fisher Scientific Revenue in CD55 Antibody Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Proteintech Group
11.3.1 Proteintech Group Company Details
11.3.2 Proteintech Group Business Overview
11.3.3 Proteintech Group CD55 Antibody Introduction
11.3.4 Proteintech Group Revenue in CD55 Antibody Business (2020-2025)
11.3.5 Proteintech Group Recent Development
11.4 Aviva Systems Biology
11.4.1 Aviva Systems Biology Company Details
11.4.2 Aviva Systems Biology Business Overview
11.4.3 Aviva Systems Biology CD55 Antibody Introduction
11.4.4 Aviva Systems Biology Revenue in CD55 Antibody Business (2020-2025)
11.4.5 Aviva Systems Biology Recent Development
11.5 LifeSpan BioSciences
11.5.1 LifeSpan BioSciences Company Details
11.5.2 LifeSpan BioSciences Business Overview
11.5.3 LifeSpan BioSciences CD55 Antibody Introduction
11.5.4 LifeSpan BioSciences Revenue in CD55 Antibody Business (2020-2025)
11.5.5 LifeSpan BioSciences Recent Development
11.6 RayBiotech
11.6.1 RayBiotech Company Details
11.6.2 RayBiotech Business Overview
11.6.3 RayBiotech CD55 Antibody Introduction
11.6.4 RayBiotech Revenue in CD55 Antibody Business (2020-2025)
11.6.5 RayBiotech Recent Development
11.7 Leading Biology
11.7.1 Leading Biology Company Details
11.7.2 Leading Biology Business Overview
11.7.3 Leading Biology CD55 Antibody Introduction
11.7.4 Leading Biology Revenue in CD55 Antibody Business (2020-2025)
11.7.5 Leading Biology Recent Development
11.8 ProSci
11.8.1 ProSci Company Details
11.8.2 ProSci Business Overview
11.8.3 ProSci CD55 Antibody Introduction
11.8.4 ProSci Revenue in CD55 Antibody Business (2020-2025)
11.8.5 ProSci Recent Development
11.9 Bethyl Laboratories
11.9.1 Bethyl Laboratories Company Details
11.9.2 Bethyl Laboratories Business Overview
11.9.3 Bethyl Laboratories CD55 Antibody Introduction
11.9.4 Bethyl Laboratories Revenue in CD55 Antibody Business (2020-2025)
11.9.5 Bethyl Laboratories Recent Development
11.10 OriGene Technologies
11.10.1 OriGene Technologies Company Details
11.10.2 OriGene Technologies Business Overview
11.10.3 OriGene Technologies CD55 Antibody Introduction
11.10.4 OriGene Technologies Revenue in CD55 Antibody Business (2020-2025)
11.10.5 OriGene Technologies Recent Development
11.11 Novus Biologicals
11.11.1 Novus Biologicals Company Details
11.11.2 Novus Biologicals Business Overview
11.11.3 Novus Biologicals CD55 Antibody Introduction
11.11.4 Novus Biologicals Revenue in CD55 Antibody Business (2020-2025)
11.11.5 Novus Biologicals Recent Development
11.12 Cell Signaling Technology
11.12.1 Cell Signaling Technology Company Details
11.12.2 Cell Signaling Technology Business Overview
11.12.3 Cell Signaling Technology CD55 Antibody Introduction
11.12.4 Cell Signaling Technology Revenue in CD55 Antibody Business (2020-2025)
11.12.5 Cell Signaling Technology Recent Development
11.13 Abcam
11.13.1 Abcam Company Details
11.13.2 Abcam Business Overview
11.13.3 Abcam CD55 Antibody Introduction
11.13.4 Abcam Revenue in CD55 Antibody Business (2020-2025)
11.13.5 Abcam Recent Development
11.14 GeneTex
11.14.1 GeneTex Company Details
11.14.2 GeneTex Business Overview
11.14.3 GeneTex CD55 Antibody Introduction
11.14.4 GeneTex Revenue in CD55 Antibody Business (2020-2025)
11.14.5 GeneTex Recent Development
11.15 United States Biological
11.15.1 United States Biological Company Details
11.15.2 United States Biological Business Overview
11.15.3 United States Biological CD55 Antibody Introduction
11.15.4 United States Biological Revenue in CD55 Antibody Business (2020-2025)
11.15.5 United States Biological Recent Development
11.16 St John's Laboratory
11.16.1 St John's Laboratory Company Details
11.16.2 St John's Laboratory Business Overview
11.16.3 St John's Laboratory CD55 Antibody Introduction
11.16.4 St John's Laboratory Revenue in CD55 Antibody Business (2020-2025)
11.16.5 St John's Laboratory Recent Development
11.17 Creative Diagnostics
11.17.1 Creative Diagnostics Company Details
11.17.2 Creative Diagnostics Business Overview
11.17.3 Creative Diagnostics CD55 Antibody Introduction
11.17.4 Creative Diagnostics Revenue in CD55 Antibody Business (2020-2025)
11.17.5 Creative Diagnostics Recent Development
11.18 Biobyt
11.18.1 Biobyt Company Details
11.18.2 Biobyt Business Overview
11.18.3 Biobyt CD55 Antibody Introduction
11.18.4 Biobyt Revenue in CD55 Antibody Business (2020-2025)
11.18.5 Biobyt Recent Development
11.19 Jingjie PTM BioLab
11.19.1 Jingjie PTM BioLab Company Details
11.19.2 Jingjie PTM BioLab Business Overview
11.19.3 Jingjie PTM BioLab CD55 Antibody Introduction
11.19.4 Jingjie PTM BioLab Revenue in CD55 Antibody Business (2020-2025)
11.19.5 Jingjie PTM BioLab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD55 Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global CD55 Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD55 Antibody Market Perspective (2020-2031)
2.2 Global CD55 Antibody Growth Trends by Region
2.2.1 Global CD55 Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CD55 Antibody Historic Market Size by Region (2020-2025)
2.2.3 CD55 Antibody Forecasted Market Size by Region (2026-2031)
2.3 CD55 Antibody Market Dynamics
2.3.1 CD55 Antibody Industry Trends
2.3.2 CD55 Antibody Market Drivers
2.3.3 CD55 Antibody Market Challenges
2.3.4 CD55 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CD55 Antibody Players by Revenue
3.1.1 Global Top CD55 Antibody Players by Revenue (2020-2025)
3.1.2 Global CD55 Antibody Revenue Market Share by Players (2020-2025)
3.2 Global CD55 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CD55 Antibody Revenue
3.4 Global CD55 Antibody Market Concentration Ratio
3.4.1 Global CD55 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD55 Antibody Revenue in 2024
3.5 Global Key Players of CD55 Antibody Head office and Area Served
3.6 Global Key Players of CD55 Antibody, Product and Application
3.7 Global Key Players of CD55 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CD55 Antibody Breakdown Data by Type
4.1 Global CD55 Antibody Historic Market Size by Type (2020-2025)
4.2 Global CD55 Antibody Forecasted Market Size by Type (2026-2031)
5 CD55 Antibody Breakdown Data by Application
5.1 Global CD55 Antibody Historic Market Size by Application (2020-2025)
5.2 Global CD55 Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CD55 Antibody Market Size (2020-2031)
6.2 North America CD55 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CD55 Antibody Market Size by Country (2020-2025)
6.4 North America CD55 Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CD55 Antibody Market Size (2020-2031)
7.2 Europe CD55 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CD55 Antibody Market Size by Country (2020-2025)
7.4 Europe CD55 Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CD55 Antibody Market Size (2020-2031)
8.2 Asia-Pacific CD55 Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CD55 Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific CD55 Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CD55 Antibody Market Size (2020-2031)
9.2 Latin America CD55 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CD55 Antibody Market Size by Country (2020-2025)
9.4 Latin America CD55 Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CD55 Antibody Market Size (2020-2031)
10.2 Middle East & Africa CD55 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CD55 Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa CD55 Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck CD55 Antibody Introduction
11.1.4 Merck Revenue in CD55 Antibody Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific CD55 Antibody Introduction
11.2.4 Thermo Fisher Scientific Revenue in CD55 Antibody Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Proteintech Group
11.3.1 Proteintech Group Company Details
11.3.2 Proteintech Group Business Overview
11.3.3 Proteintech Group CD55 Antibody Introduction
11.3.4 Proteintech Group Revenue in CD55 Antibody Business (2020-2025)
11.3.5 Proteintech Group Recent Development
11.4 Aviva Systems Biology
11.4.1 Aviva Systems Biology Company Details
11.4.2 Aviva Systems Biology Business Overview
11.4.3 Aviva Systems Biology CD55 Antibody Introduction
11.4.4 Aviva Systems Biology Revenue in CD55 Antibody Business (2020-2025)
11.4.5 Aviva Systems Biology Recent Development
11.5 LifeSpan BioSciences
11.5.1 LifeSpan BioSciences Company Details
11.5.2 LifeSpan BioSciences Business Overview
11.5.3 LifeSpan BioSciences CD55 Antibody Introduction
11.5.4 LifeSpan BioSciences Revenue in CD55 Antibody Business (2020-2025)
11.5.5 LifeSpan BioSciences Recent Development
11.6 RayBiotech
11.6.1 RayBiotech Company Details
11.6.2 RayBiotech Business Overview
11.6.3 RayBiotech CD55 Antibody Introduction
11.6.4 RayBiotech Revenue in CD55 Antibody Business (2020-2025)
11.6.5 RayBiotech Recent Development
11.7 Leading Biology
11.7.1 Leading Biology Company Details
11.7.2 Leading Biology Business Overview
11.7.3 Leading Biology CD55 Antibody Introduction
11.7.4 Leading Biology Revenue in CD55 Antibody Business (2020-2025)
11.7.5 Leading Biology Recent Development
11.8 ProSci
11.8.1 ProSci Company Details
11.8.2 ProSci Business Overview
11.8.3 ProSci CD55 Antibody Introduction
11.8.4 ProSci Revenue in CD55 Antibody Business (2020-2025)
11.8.5 ProSci Recent Development
11.9 Bethyl Laboratories
11.9.1 Bethyl Laboratories Company Details
11.9.2 Bethyl Laboratories Business Overview
11.9.3 Bethyl Laboratories CD55 Antibody Introduction
11.9.4 Bethyl Laboratories Revenue in CD55 Antibody Business (2020-2025)
11.9.5 Bethyl Laboratories Recent Development
11.10 OriGene Technologies
11.10.1 OriGene Technologies Company Details
11.10.2 OriGene Technologies Business Overview
11.10.3 OriGene Technologies CD55 Antibody Introduction
11.10.4 OriGene Technologies Revenue in CD55 Antibody Business (2020-2025)
11.10.5 OriGene Technologies Recent Development
11.11 Novus Biologicals
11.11.1 Novus Biologicals Company Details
11.11.2 Novus Biologicals Business Overview
11.11.3 Novus Biologicals CD55 Antibody Introduction
11.11.4 Novus Biologicals Revenue in CD55 Antibody Business (2020-2025)
11.11.5 Novus Biologicals Recent Development
11.12 Cell Signaling Technology
11.12.1 Cell Signaling Technology Company Details
11.12.2 Cell Signaling Technology Business Overview
11.12.3 Cell Signaling Technology CD55 Antibody Introduction
11.12.4 Cell Signaling Technology Revenue in CD55 Antibody Business (2020-2025)
11.12.5 Cell Signaling Technology Recent Development
11.13 Abcam
11.13.1 Abcam Company Details
11.13.2 Abcam Business Overview
11.13.3 Abcam CD55 Antibody Introduction
11.13.4 Abcam Revenue in CD55 Antibody Business (2020-2025)
11.13.5 Abcam Recent Development
11.14 GeneTex
11.14.1 GeneTex Company Details
11.14.2 GeneTex Business Overview
11.14.3 GeneTex CD55 Antibody Introduction
11.14.4 GeneTex Revenue in CD55 Antibody Business (2020-2025)
11.14.5 GeneTex Recent Development
11.15 United States Biological
11.15.1 United States Biological Company Details
11.15.2 United States Biological Business Overview
11.15.3 United States Biological CD55 Antibody Introduction
11.15.4 United States Biological Revenue in CD55 Antibody Business (2020-2025)
11.15.5 United States Biological Recent Development
11.16 St John's Laboratory
11.16.1 St John's Laboratory Company Details
11.16.2 St John's Laboratory Business Overview
11.16.3 St John's Laboratory CD55 Antibody Introduction
11.16.4 St John's Laboratory Revenue in CD55 Antibody Business (2020-2025)
11.16.5 St John's Laboratory Recent Development
11.17 Creative Diagnostics
11.17.1 Creative Diagnostics Company Details
11.17.2 Creative Diagnostics Business Overview
11.17.3 Creative Diagnostics CD55 Antibody Introduction
11.17.4 Creative Diagnostics Revenue in CD55 Antibody Business (2020-2025)
11.17.5 Creative Diagnostics Recent Development
11.18 Biobyt
11.18.1 Biobyt Company Details
11.18.2 Biobyt Business Overview
11.18.3 Biobyt CD55 Antibody Introduction
11.18.4 Biobyt Revenue in CD55 Antibody Business (2020-2025)
11.18.5 Biobyt Recent Development
11.19 Jingjie PTM BioLab
11.19.1 Jingjie PTM BioLab Company Details
11.19.2 Jingjie PTM BioLab Business Overview
11.19.3 Jingjie PTM BioLab CD55 Antibody Introduction
11.19.4 Jingjie PTM BioLab Revenue in CD55 Antibody Business (2020-2025)
11.19.5 Jingjie PTM BioLab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CD55 Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal
Table 3. Key Players of Polyclonal
Table 4. Global CD55 Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global CD55 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global CD55 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global CD55 Antibody Market Share by Region (2020-2025)
Table 8. Global CD55 Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global CD55 Antibody Market Share by Region (2026-2031)
Table 10. CD55 Antibody Market Trends
Table 11. CD55 Antibody Market Drivers
Table 12. CD55 Antibody Market Challenges
Table 13. CD55 Antibody Market Restraints
Table 14. Global CD55 Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global CD55 Antibody Market Share by Players (2020-2025)
Table 16. Global Top CD55 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD55 Antibody as of 2024)
Table 17. Ranking of Global Top CD55 Antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by CD55 Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of CD55 Antibody, Headquarters and Area Served
Table 20. Global Key Players of CD55 Antibody, Product and Application
Table 21. Global Key Players of CD55 Antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CD55 Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global CD55 Antibody Revenue Market Share by Type (2020-2025)
Table 25. Global CD55 Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global CD55 Antibody Revenue Market Share by Type (2026-2031)
Table 27. Global CD55 Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global CD55 Antibody Revenue Market Share by Application (2020-2025)
Table 29. Global CD55 Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global CD55 Antibody Revenue Market Share by Application (2026-2031)
Table 31. North America CD55 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America CD55 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America CD55 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe CD55 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe CD55 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe CD55 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific CD55 Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific CD55 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific CD55 Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America CD55 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America CD55 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America CD55 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa CD55 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa CD55 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa CD55 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. Merck Company Details
Table 47. Merck Business Overview
Table 48. Merck CD55 Antibody Product
Table 49. Merck Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific CD55 Antibody Product
Table 54. Thermo Fisher Scientific Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Proteintech Group Company Details
Table 57. Proteintech Group Business Overview
Table 58. Proteintech Group CD55 Antibody Product
Table 59. Proteintech Group Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 60. Proteintech Group Recent Development
Table 61. Aviva Systems Biology Company Details
Table 62. Aviva Systems Biology Business Overview
Table 63. Aviva Systems Biology CD55 Antibody Product
Table 64. Aviva Systems Biology Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 65. Aviva Systems Biology Recent Development
Table 66. LifeSpan BioSciences Company Details
Table 67. LifeSpan BioSciences Business Overview
Table 68. LifeSpan BioSciences CD55 Antibody Product
Table 69. LifeSpan BioSciences Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 70. LifeSpan BioSciences Recent Development
Table 71. RayBiotech Company Details
Table 72. RayBiotech Business Overview
Table 73. RayBiotech CD55 Antibody Product
Table 74. RayBiotech Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 75. RayBiotech Recent Development
Table 76. Leading Biology Company Details
Table 77. Leading Biology Business Overview
Table 78. Leading Biology CD55 Antibody Product
Table 79. Leading Biology Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 80. Leading Biology Recent Development
Table 81. ProSci Company Details
Table 82. ProSci Business Overview
Table 83. ProSci CD55 Antibody Product
Table 84. ProSci Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 85. ProSci Recent Development
Table 86. Bethyl Laboratories Company Details
Table 87. Bethyl Laboratories Business Overview
Table 88. Bethyl Laboratories CD55 Antibody Product
Table 89. Bethyl Laboratories Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 90. Bethyl Laboratories Recent Development
Table 91. OriGene Technologies Company Details
Table 92. OriGene Technologies Business Overview
Table 93. OriGene Technologies CD55 Antibody Product
Table 94. OriGene Technologies Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 95. OriGene Technologies Recent Development
Table 96. Novus Biologicals Company Details
Table 97. Novus Biologicals Business Overview
Table 98. Novus Biologicals CD55 Antibody Product
Table 99. Novus Biologicals Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 100. Novus Biologicals Recent Development
Table 101. Cell Signaling Technology Company Details
Table 102. Cell Signaling Technology Business Overview
Table 103. Cell Signaling Technology CD55 Antibody Product
Table 104. Cell Signaling Technology Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 105. Cell Signaling Technology Recent Development
Table 106. Abcam Company Details
Table 107. Abcam Business Overview
Table 108. Abcam CD55 Antibody Product
Table 109. Abcam Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 110. Abcam Recent Development
Table 111. GeneTex Company Details
Table 112. GeneTex Business Overview
Table 113. GeneTex CD55 Antibody Product
Table 114. GeneTex Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 115. GeneTex Recent Development
Table 116. United States Biological Company Details
Table 117. United States Biological Business Overview
Table 118. United States Biological CD55 Antibody Product
Table 119. United States Biological Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 120. United States Biological Recent Development
Table 121. St John's Laboratory Company Details
Table 122. St John's Laboratory Business Overview
Table 123. St John's Laboratory CD55 Antibody Product
Table 124. St John's Laboratory Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 125. St John's Laboratory Recent Development
Table 126. Creative Diagnostics Company Details
Table 127. Creative Diagnostics Business Overview
Table 128. Creative Diagnostics CD55 Antibody Product
Table 129. Creative Diagnostics Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 130. Creative Diagnostics Recent Development
Table 131. Biobyt Company Details
Table 132. Biobyt Business Overview
Table 133. Biobyt CD55 Antibody Product
Table 134. Biobyt Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 135. Biobyt Recent Development
Table 136. Jingjie PTM BioLab Company Details
Table 137. Jingjie PTM BioLab Business Overview
Table 138. Jingjie PTM BioLab CD55 Antibody Product
Table 139. Jingjie PTM BioLab Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 140. Jingjie PTM BioLab Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
Table 144. Authors List of This Report
List of Figures
Figure 1. CD55 Antibody Picture
Figure 2. Global CD55 Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CD55 Antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Features
Figure 5. Polyclonal Features
Figure 6. Global CD55 Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global CD55 Antibody Market Share by Application: 2024 VS 2031
Figure 8. Immunochemistry (IHC) Case Studies
Figure 9. Immunofluorescence (IF) Case Studies
Figure 10. Immunoprecipitation (IP) Case Studies
Figure 11. Western Blot (WB) Case Studies
Figure 12. ELISA Case Studies
Figure 13. Others Case Studies
Figure 14. CD55 Antibody Report Years Considered
Figure 15. Global CD55 Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global CD55 Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global CD55 Antibody Market Share by Region: 2024 VS 2031
Figure 18. Global CD55 Antibody Market Share by Players in 2024
Figure 19. Global Top CD55 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD55 Antibody as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by CD55 Antibody Revenue in 2024
Figure 21. North America CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America CD55 Antibody Market Share by Country (2020-2031)
Figure 23. United States CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe CD55 Antibody Market Share by Country (2020-2031)
Figure 27. Germany CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific CD55 Antibody Market Share by Region (2020-2031)
Figure 35. China CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America CD55 Antibody Market Share by Country (2020-2031)
Figure 43. Mexico CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa CD55 Antibody Market Share by Country (2020-2031)
Figure 47. Turkey CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Merck Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 52. Proteintech Group Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 53. Aviva Systems Biology Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 54. LifeSpan BioSciences Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 55. RayBiotech Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 56. Leading Biology Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 57. ProSci Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 58. Bethyl Laboratories Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 59. OriGene Technologies Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 60. Novus Biologicals Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 61. Cell Signaling Technology Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 62. Abcam Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 63. GeneTex Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 64. United States Biological Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 65. St John's Laboratory Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 66. Creative Diagnostics Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 67. Biobyt Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 68. Jingjie PTM BioLab Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Table 1. Global CD55 Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal
Table 3. Key Players of Polyclonal
Table 4. Global CD55 Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global CD55 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global CD55 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global CD55 Antibody Market Share by Region (2020-2025)
Table 8. Global CD55 Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global CD55 Antibody Market Share by Region (2026-2031)
Table 10. CD55 Antibody Market Trends
Table 11. CD55 Antibody Market Drivers
Table 12. CD55 Antibody Market Challenges
Table 13. CD55 Antibody Market Restraints
Table 14. Global CD55 Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global CD55 Antibody Market Share by Players (2020-2025)
Table 16. Global Top CD55 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD55 Antibody as of 2024)
Table 17. Ranking of Global Top CD55 Antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by CD55 Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of CD55 Antibody, Headquarters and Area Served
Table 20. Global Key Players of CD55 Antibody, Product and Application
Table 21. Global Key Players of CD55 Antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CD55 Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global CD55 Antibody Revenue Market Share by Type (2020-2025)
Table 25. Global CD55 Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global CD55 Antibody Revenue Market Share by Type (2026-2031)
Table 27. Global CD55 Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global CD55 Antibody Revenue Market Share by Application (2020-2025)
Table 29. Global CD55 Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global CD55 Antibody Revenue Market Share by Application (2026-2031)
Table 31. North America CD55 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America CD55 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America CD55 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe CD55 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe CD55 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe CD55 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific CD55 Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific CD55 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific CD55 Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America CD55 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America CD55 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America CD55 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa CD55 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa CD55 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa CD55 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. Merck Company Details
Table 47. Merck Business Overview
Table 48. Merck CD55 Antibody Product
Table 49. Merck Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific CD55 Antibody Product
Table 54. Thermo Fisher Scientific Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Proteintech Group Company Details
Table 57. Proteintech Group Business Overview
Table 58. Proteintech Group CD55 Antibody Product
Table 59. Proteintech Group Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 60. Proteintech Group Recent Development
Table 61. Aviva Systems Biology Company Details
Table 62. Aviva Systems Biology Business Overview
Table 63. Aviva Systems Biology CD55 Antibody Product
Table 64. Aviva Systems Biology Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 65. Aviva Systems Biology Recent Development
Table 66. LifeSpan BioSciences Company Details
Table 67. LifeSpan BioSciences Business Overview
Table 68. LifeSpan BioSciences CD55 Antibody Product
Table 69. LifeSpan BioSciences Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 70. LifeSpan BioSciences Recent Development
Table 71. RayBiotech Company Details
Table 72. RayBiotech Business Overview
Table 73. RayBiotech CD55 Antibody Product
Table 74. RayBiotech Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 75. RayBiotech Recent Development
Table 76. Leading Biology Company Details
Table 77. Leading Biology Business Overview
Table 78. Leading Biology CD55 Antibody Product
Table 79. Leading Biology Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 80. Leading Biology Recent Development
Table 81. ProSci Company Details
Table 82. ProSci Business Overview
Table 83. ProSci CD55 Antibody Product
Table 84. ProSci Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 85. ProSci Recent Development
Table 86. Bethyl Laboratories Company Details
Table 87. Bethyl Laboratories Business Overview
Table 88. Bethyl Laboratories CD55 Antibody Product
Table 89. Bethyl Laboratories Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 90. Bethyl Laboratories Recent Development
Table 91. OriGene Technologies Company Details
Table 92. OriGene Technologies Business Overview
Table 93. OriGene Technologies CD55 Antibody Product
Table 94. OriGene Technologies Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 95. OriGene Technologies Recent Development
Table 96. Novus Biologicals Company Details
Table 97. Novus Biologicals Business Overview
Table 98. Novus Biologicals CD55 Antibody Product
Table 99. Novus Biologicals Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 100. Novus Biologicals Recent Development
Table 101. Cell Signaling Technology Company Details
Table 102. Cell Signaling Technology Business Overview
Table 103. Cell Signaling Technology CD55 Antibody Product
Table 104. Cell Signaling Technology Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 105. Cell Signaling Technology Recent Development
Table 106. Abcam Company Details
Table 107. Abcam Business Overview
Table 108. Abcam CD55 Antibody Product
Table 109. Abcam Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 110. Abcam Recent Development
Table 111. GeneTex Company Details
Table 112. GeneTex Business Overview
Table 113. GeneTex CD55 Antibody Product
Table 114. GeneTex Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 115. GeneTex Recent Development
Table 116. United States Biological Company Details
Table 117. United States Biological Business Overview
Table 118. United States Biological CD55 Antibody Product
Table 119. United States Biological Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 120. United States Biological Recent Development
Table 121. St John's Laboratory Company Details
Table 122. St John's Laboratory Business Overview
Table 123. St John's Laboratory CD55 Antibody Product
Table 124. St John's Laboratory Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 125. St John's Laboratory Recent Development
Table 126. Creative Diagnostics Company Details
Table 127. Creative Diagnostics Business Overview
Table 128. Creative Diagnostics CD55 Antibody Product
Table 129. Creative Diagnostics Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 130. Creative Diagnostics Recent Development
Table 131. Biobyt Company Details
Table 132. Biobyt Business Overview
Table 133. Biobyt CD55 Antibody Product
Table 134. Biobyt Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 135. Biobyt Recent Development
Table 136. Jingjie PTM BioLab Company Details
Table 137. Jingjie PTM BioLab Business Overview
Table 138. Jingjie PTM BioLab CD55 Antibody Product
Table 139. Jingjie PTM BioLab Revenue in CD55 Antibody Business (2020-2025) & (US$ Million)
Table 140. Jingjie PTM BioLab Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
Table 144. Authors List of This Report
List of Figures
Figure 1. CD55 Antibody Picture
Figure 2. Global CD55 Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CD55 Antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Features
Figure 5. Polyclonal Features
Figure 6. Global CD55 Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global CD55 Antibody Market Share by Application: 2024 VS 2031
Figure 8. Immunochemistry (IHC) Case Studies
Figure 9. Immunofluorescence (IF) Case Studies
Figure 10. Immunoprecipitation (IP) Case Studies
Figure 11. Western Blot (WB) Case Studies
Figure 12. ELISA Case Studies
Figure 13. Others Case Studies
Figure 14. CD55 Antibody Report Years Considered
Figure 15. Global CD55 Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global CD55 Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global CD55 Antibody Market Share by Region: 2024 VS 2031
Figure 18. Global CD55 Antibody Market Share by Players in 2024
Figure 19. Global Top CD55 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD55 Antibody as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by CD55 Antibody Revenue in 2024
Figure 21. North America CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America CD55 Antibody Market Share by Country (2020-2031)
Figure 23. United States CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe CD55 Antibody Market Share by Country (2020-2031)
Figure 27. Germany CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific CD55 Antibody Market Share by Region (2020-2031)
Figure 35. China CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America CD55 Antibody Market Share by Country (2020-2031)
Figure 43. Mexico CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa CD55 Antibody Market Share by Country (2020-2031)
Figure 47. Turkey CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE CD55 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Merck Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 52. Proteintech Group Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 53. Aviva Systems Biology Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 54. LifeSpan BioSciences Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 55. RayBiotech Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 56. Leading Biology Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 57. ProSci Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 58. Bethyl Laboratories Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 59. OriGene Technologies Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 60. Novus Biologicals Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 61. Cell Signaling Technology Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 62. Abcam Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 63. GeneTex Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 64. United States Biological Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 65. St John's Laboratory Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 66. Creative Diagnostics Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 67. Biobyt Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 68. Jingjie PTM BioLab Revenue Growth Rate in CD55 Antibody Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232